General Description
Odorless white crystals. Used as a dietary supplement and food additive.
Reactivity Profile
Flammable and/or toxic gases are generated by the combination of alcohols with alkali metals, nitrides, and strong reducing agents. They react with oxoacids and carboxylic acids to form esters plus water. Oxidizing agents convert them to aldehydes or ketones. Alcohols exhibit both weak acid and weak base behavior. They may initiate the polymerization of isocyanates and epoxides.
Health Hazard
Ergocalciferol poisoning disturbs calcium metabolism and causes kidney damage. Ergocalciferol in a single acute ingestion presents no toxic hazards. Daily ingestion in excess of 5000 units/day in children or 7500 units/day in adults will produce toxic symptoms associated with hypervitaminosis D. Those with hypercalcemia are at a greater risk.
Potential Exposure
Used as a nutrient and/or dietary supplement food additive
Fire Hazard
Shows signs of decomposition when stored for a few days at room temperature.
First aid
If this chemical gets into the eyes, remove any
contact lenses at once and irrigate immediately for at least
15 minutes, occasionally lifting upper and lower lids. Seek
medical attention immediately. If this chemical contacts
the skin, remove contaminated clothing and wash immediately with soap and water. Seek medical attention immediately. If this chemical has been inhaled, remove from
exposure, begin rescue breathing (using universal precautions, including resuscitation mask) if breathing has
stopped and CPR if heart action has stopped. Transfer
promptly to a medical facility. When this chemical has
been swallowed, get medical attention. Give large quantities of water and induce vomiting. Do not make an unconscious person vomit
Shipping
UN2811 Toxic solids, organic, n.o.s., Hazard
Class: 6.1; Labels: 6.1-Poisonous materials, Technical
Name Required. UN3249 Medicine, solid, toxic, n.o.s.,
Hazard Class: 6.1; Labels: 6.1-Poisonous materials
Incompatibilities
Dust may be combustible and may form
explosive mixture with air. Incompatible with oxidizers
(chlorates, nitrates, peroxides, permanganates, perchlorates,
chlorine, bromine, fluorine, etc.); contact may cause fires
or explosions. Keep away from alkaline materials, strong
bases, strong acids, oxoacids, and epoxides.
Waste Disposal
Dispose of contents and container to an approved waste disposal plant. All federal,
state, and local environmental regulations must be
observed. It is inappropriate and possibly dangerous to the
environment to dispose of expired or waste drugs and pharmaceuticals by flushing them down the toilet or discarding
them to the trash. Household quantities of expired or waste
pharmaceuticals may be mixed with wet cat litter or coffeegrounds, double-bagged in plastic, discard in trash. Larger
quantities shall carefully take into consideration applicable
DEA, EPA, and FDA regulations. If possible return the
pharmaceutical to the manufacturer for proper disposal
being careful to properly label and securely package the
material. Alternatively, the waste pharmaceutical shall be
labeled, securely packaged and transported by a state
licensed medical waste contractor to dispose by burial in a
licensed hazardous or toxic waste landfill or incinerator.
Definition
ChEBI: A vitamin D supplement and has been isolated from alfalfa.
Brand name
Deltalin (Lilly); Drisdol(Sanofi Aventis).
Biochem/physiol Actions
Ergocalciferol (vitamin D2) and 25-Hydroxycholecalciferol (vitamin D3) are the two form of vitamin D which are activated in vivo by hydroxylation. Vitamin D2 and D3 may be used in a wide range of studies to assess their effects on function such as immune function and calcium homeostasis.
Metabolic pathway
Ergocalciferol (vitamin D2) is a product made by the UV irradiation of
yeast ergosterol. It is a common form of vitamin D and it has very similar
biological activity to that of cholecalciferol (vitamin D3) in the treatment of
the vitamin D deficiency diseases (e.g. rickets). The bioactive form of this
vitamin is also the 1,25-dihydroxy-derivative and this has equal antirachitic
activity to that of the cholecalciferol analogue (Jones et al., 1975).
Purification Methods
It is converted into its 3,5-dinitrobenzoyl ester and crystallised repeatedly from acetone. The ester is then saponified and the free vitamin is isolated. [Laughland & Phillips Anal Chem 28 817 1956, Beilstein 6 IV 4404.]
Degradation
It is unstable in light and air and in acidic media.
It is inactivated within a few days under normal exposure conditions. This
is due to oxidation and fragmentation of the triene functionality. Ergocalciferol
is slightly more unstable, probably because of the additional
alkene group in the side chain. One of the several degradation products of
ergocalciferol has been identified as the ketone (8, shown in Scheme 1)
formed by the loss of the methano-cyclohexanol function (Stewart et al.,
1984).
Toxicity evaluation
Excess vitamin D in the form of 1,25-dihydroxycalciferol results
in hypercalcemia and hypercalciuria, due to increased calcium
absorption, bone demineralization, and hyperphosphatemia.